Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount summary - Europe pre-Open: Futures: FTSE (0.09%), DAX (0.01%), CAC (0.07%)

Jun 05 ,2025

  • Synopsis

    • European equity markets are set to open in negative territory amidst Asian equities mostly higher Thursday. Korea extending post-election rally though off best levels. Hong Kong also off highs with mainland indexes flat. Japan veering into negative territory. Tepid gains in Taiwan while Australia unchanged. S&P 500 futures flat afterhours. Bonds mixed with JGB curve bull flattening ahead of 30Y auction. Treasuries little changed following dovish reaction to soft data overnight. Dollar steady after nearing late April lows. Crude pulling back from earlier highs. Gold and Bitcoin unchanged.

    • On today's agenda, NATO defense ministers' meeting takes place. In Germany, in the afternoon, Chancellor Merz holds regular meeting with the State Premiers, a joint press conf is planned afterward. EU transport ministers' meeting and EU Digita Summit 2025. Also, Brussels Economic Security Forum, EU's Virkkunen delivers a speeches at both, EU's Šefčovič at the latter. In the UK, MPs debate on a motion on high street banking closures and banking hubs. Norwegian Offshore Directorate's Technology Day. Germany, UK May new car registrations.

    • In central banks, focus on ECB interest rate decision at 14:15CET, cut of 25bps in benchmark rate to 2.0% expected, post decision press conf 14:45. BOE's Greene speech at 8:45BST at ECONDAT conf. Bundesbank's Köhler-Geib panellist at 11:15CET at event hosted by European School of Management and Technology whilst Bundesbank's Mauderer speech at 17:00CET at ICMA AGM. ECB's Machado panellist at 15:10CET at EFDI International Conf. ECB media seminar 2025 (through Fri), speakers include ECB's Donnery at 11:30CET, Schnabel at 17:00. Slovakia central bank / SUERFconf whilst Czech central bank publishes latest Financial Stability Report.

    • Macroeconomic updates include: Germany Apr factory orders, May construction PMI, Switzerland May unemployment rate, UK May construction PMI, Italy Apr retail sales, Sweden May preliminary CPI, Eurozone Apr PPI, Ireland May unemployment rate.

    • In corporate news, Valmet (VALMT.FH) announced yesterday after the close new strategy, reiterated 2025 guidance and published new 2030 financial targets. This morning, Burckhardt Compression Holding (BCHN.SW) released FY earnings as well as announced upcoming changes in the board. Systemair (SYSR.SS) posted Q4 earnings and proposed a dividend of SEK1.35/share vs year-ago SEK1.20/share. In the UK, Wise (WISE.LN), Mitie Group (MTO.LN) and Wizz Air Holdings (WIZZ.LN) are expected to update the market with their most recent numbers.

    • On M&A front, L'Oreal (OR.FP) set to agree €1B deal to acquire skincare company Medik8, FT reported.

    • CMD/events: Mota-Engil (EGL.PL), Valmet (VALMT.FH)

  • Politics/Macro/World News

    • Saudi Arabia wants more super-size OPEC+ hikes - Bloomberg

    • Nato defence ministers to discuss path to 5% military spending - FT

    • UK home sales hit three-year high, defying slowdown fears - Bloomberg

    • Global energy investment set to increase in 2025 to record $3.3T with clean energy technologies attracting twice as much capital as fossil fuels - IEA report

  • Top company news

    • Earnings/updates

      • VALMT.FH (Valmet) -- announces new strategy; publishes new 2030 financial targets

      • BCHN.SW (Burckhardt Compression Holding) -- reports FY EPS CHF31.20 vs FactSet CHF30.55 [3 est, CHF29.11-31.77]

      • SYSR.SS (Systemair) -- reports Q4 EPS SEK0.50 vs FactSet SEK0.89 [5 est, SEK0.66-1.10]

    • M&A

      • OR.FP (L'Oreal) -- set to agree €1B deal to acquire skincare company Medik8 - FT

      • BPSO.IM (Banca Popolare di Sondrio) -- Consob approves offer document in connection with BPER Banca's acquisition of Banca Popolare di Sondrio

      • SESG.FP (SES) -- set to win unconditional EU antitrust approval for proposed acquisition of Intelsat - Reuters, citing people familiar with the matter

      • BAMI.IM (Banco BPM) -- UniCredit receives EU Commission clearance in connection with offer for Banco BPM pursuant to the Foreign Subsidiary Regulation

      • SBMO.NA (SBM Offshore) -- announces agreement to divest interest in FPSO Aseng

      • ACE.IM (ACEA) -- receives offer from Eni Plentitude for Energia subsidiary

      • BLV.FP (Believe) -- Upbeat Bidco increases offer for Believe €17.20/sh from €15.30/sr

      • INSE.LN (Inspired) -- announces valid acceptances received for total ~ 172.5K shares

      • EKTA.B.SS (Elekta) -- acquires assets from its distributor in Croatia

    • Healthcare

      • ADXN.SW (Addex Therapeutics) -- Addex to present positive GABAB PAM chronic cough data at the 10th American Cough Conference

      • EAPI.FP (Euroapi) -- appoints Frédéric Robert to newly created position of Chief Commercial Officer overseeing API Solutions and CDMO activities

      • CLARI.FP (Clariane) -- renews the drawdown under the Revolving Credit Facility for a six-month period

      • FYB.GR (Formycon) -- receives marketing authorization for Ranivisio in Brazil

      • CRNA.NO (Circio Holding) -- ASA announces holder Atlas requests conversion of convertible bonds with nominal value of NOK 2.5M

    • Other

      • WLN.FP (Worldline) -- announces results of offer to repurchase OCEANEs due Jul-26

      • COL.SM (Inmobiliaria Colonial SOCIMI) -- completes share buy-back program

  • Key rating changes

    • Upgrades

      • ENGI.FP (ENGIE) - to overweight from equal weight at Barclays

    • Downgrades

      • AKZA.NA (Akzo Nobel) -- to neutral from buy at UBS

      • EOAN.GR (E.ON SE) -- to equal weight from overweight at Barclays

      • SRG.IM (Snam) -- to equal weight from overweight at Barclays

  • Data

    • Nikkei (0.42%) to 37590.33

    • Hang Seng +0.48% to 23768.17

    • Shanghai Composite +0.00% to 3376.35

    • S&P futures (6.3) vs prior close of 5981.0

    • €-$ (0.0009) or (0.08%) to 1.1412

    • $-¥ +0.32 or +0.22% to 143.10

    • €-¥ +0.27 or +0.17% to 163.30

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE